Summit Therapeutics Inc
For the period ended Dec 31, 2024. Filed Feb 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 24, 2025
SMMT$17.84+9.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
The following table provides information concerning Summit’s principal leased facilities as of December 31, 2024:
We maintain the following leased properties:
| Type/Uses | Location | Size | Lease Expiration |
|---|---|---|---|
| Headquarters | Miami, Florida | 9,425 square feet | April 2029 |
| Executive office | Oxfordshire, United Kingdom | 6,781 square feet | February 2027 |
| Executive office | Menlo Park, California | 17,745 square feet | December 2025 to May 2026 |
We believe our facilities are suitable and adequate to meet our needs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.